Search
Kenvue Inc
KVUEAdd to Watchlist
18.960USD
+0.160+0.85%
Close 06/25, 16:00（ET）Quotes delayed by 15 min
36.40BMarket Cap
22.42P/E TTM
More Details of Kenvue Inc Company
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Kenvue Inc Info
Ticker SymbolKVUE
Company nameKenvue Inc
IPO dateMay 04, 2023
CEOPerry (Kirk L)
Number of employees22000
Security typeOrdinary Share
Fiscal year-endMay 04
Address1 Kenvue Way
CitySUMMIT
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code07901
Phone19088741200
Websitehttps://www.kenvue.com
Ticker SymbolKVUE
IPO dateMay 04, 2023
CEOPerry (Kirk L)
Company Executives of Kenvue Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
111.42K
+12.47%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
93.62K
+8.09%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
76.92K
+18.68%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+28.19%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
40.94K
--
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
37.10K
+70.93%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+13.30%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.38%
Ms. Melanie L. Healey
Ms. Melanie L. Healey
Independent Director
Independent Director
26.47K
+99.43%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
111.42K
+12.47%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
93.62K
+8.09%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
76.92K
+18.68%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+28.19%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
40.94K
--
FAQs
Who are the top five shareholders of Kenvue Inc?
The top five shareholders of Kenvue Inc are: Mr. Carlton Lawson
How many institutions hold shares of Kenvue Inc (KVUE)?
As of 2026Q1, 2195 institutions hold shares of Kenvue Inc, with a combined market value of approximately 1.82B, accounting for 94.75% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -195892523.00.
What is the biggest source of revenue for Kenvue Inc?
In 2026Q1, the Face and Body Care business generated the highest revenue for Kenvue Inc, amounting to 2.87B and accounting for 19.00% of total revenue.
